BUY ZYCAN MEDICINE ONLINE 

Zycan is a Disease Modifying Osteoarthritis Drug (DMOAD) for the treatment and prevention of clinical signs attributable to degenerative and/or traumatic aseptic joint disease in horses. DMOADs are intended to prevent, retard or reverse theZycan is a Disease Modifying Osteoarthritis Drug (DMOAD) for the treatment and prevention of clinical signs attributable to degenerative and/or traumatic aseptic joint disease in horses. DMOADs are intended to prevent, retard or reverse themorphologic cartilaginous lesions associated with degenerative joint disease (DJD)…
PSGAGs, such as Zycan have been advocated for the (i) praventative treatment of joint disease (il) chronic joint maintenance programs and (i) post-operative care of horses returning to training following joint surgery. High Performance Joint and Bone Therapies. Back to Veterinary Medicines. Zycan Injection. For treatment of lameness due to degenerative aseptic joint. Statement of Hazardous Nature This product is classified as: Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to Australian Dangerous Goods (ADG) Code.

WHERE TO BUY ZYCAN HORSE MEDICATION IN EUROPE

RESPONSE
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P370+P378: Not combustible. Use extinguishing media suited to burning materials.
STORAGE
P403: Store in a well-ventilated place.
P410: Protect from sunlight.
P411: Store at temperatures not exceeding 25°C.
P402+P404: Store in a dry place. Store in a closed container.
DISPOSAL
P501: Dispose of small quantities and empty containers by wrapping with paper and putting in garbage.
For larger quantities, if recycling or reclaiming is not possible, use a commercial waste disposal service.
EMERGENCY OVERVIEW
Physical Description & Colour: Clear pale straw-coloured liquid.
Odour: Mild odour.
Major Health Hazards: no significant risk factors have been found for this product.
IATA or IMDG/IMSBC criteria.
SUSMP Classification: None allocated
ADG Classification: None allocated. Not a Dangerous Good according to Australian Dangerous Goods (ADG)
Code, IATA or IMDG/IMSBC criteria.
UN Number: None allocated.
GHS Signal word: NONE. Not hazardous.

WHERE TO STORE ZYCAN DRUGS

The best place to store liquids and pastes is in a climate-controlled space that keeps them at the temperature range indicated on the label. The house or a heated tack room or garage is one option, as is a refrigerator. For powders and pills, you can store the amount you are likely to use in a week in the feed room.

PRECAUTION ON ZYCAN ANIMAL MEDICINE

Precautions IM PSGAG administration may occasionally result in transient localised swelling and discomfort at the injection site. As PSGAGs have heparinoid activity, do not administer when a pre-existent tendency to haemorrhage or increased coagulation time is expected. Do not administer within 24 hours of surgery. IA PSGAG administration may cause a post-injection inflammation (joint pain, effusion, swelling and lameness) secondary to sensitivity reactions. A slightly increased risk of joint infections following IA injection of 250mg PSGAG has been reported compared with corticosteroids + HA. Zycan should not be used in place of other therapies (such as joint flushes and antibiotics) when joint infection is present or suspected. Safety in pregnant or lactating animals or in foals has not been established. Use with caution in these groups. Caution should be taken when administered to horses with advanced renal or hepatic disease. Do not mix Zycan with other drugs or solvents.

WHAT IS ZYCAN

Zycan is a Disease Modifying Osteoarthritis Drug (DMOAD) for the treatment and prevention of clinical signs attributable to degenerative and/or traumatic aseptic joint disease in horses. DMOADs are intended to prevent, retard or reverse the morphologic cartilaginous lesions associated with degenerative joint disease (DJD). PSGAGs, such as Zycan have been advocated for the (i) preventative treatment of joint disease (ii) chronic joint maintenance programs and (iii) post-operative care of horses returning to training following joint surgery.